Overview
- Three possible fates
- enter citric acid cycle
- form ketone bodies
- substrates for gluconeogenesis
- Urea cycle
- function
- degrade excess amino acids and safely remove nitrogen
- surplus amino acids cannot be stored
- produce urea
- degrade excess amino acids and safely remove nitrogen
- pathway
- aspartate and carbamoyl phosphate provide nitrogens
- carbamoyl phosphate synthesized from NH4+ + HCO3– + 2 ATP via carbamoyl phosphate synthetase I
- rate determining step of pathway
- requires N-acetylglutamate which regulates the cycle
- only produced when excess amino acids are present
- carbamoyl phosphate synthesized from NH4+ + HCO3– + 2 ATP via carbamoyl phosphate synthetase I
- nitrogen added from systemic pool via alanine cycle
- one turn of the cycle:
- aspartate + NH3 + CO2 + 3 ATP → urea (containing 2N)+ fumarate + 2 ADP + Pi + AMP + PPi + 3 H20
- connected to citric acid cycle
- via aspartate-argininosuccinate shunt
- fumarate of urea cycle → malate of citric acid cycle
- oxaloacetate of citric acid cycle → aspartate of urea cycle
- via aspartate-argininosuccinate shunt
- aspartate and carbamoyl phosphate provide nitrogens
- location
- cellularly
- formation of carbamoyl phosphate occurs in the mitochondrial matrix
- addition of aspartate and removal of fumarate and urea occurs in the cytoplasm
- systemic
- liver and kidney
- cellularly
- deficiencies
- common presentation
- hyperammonemia + ↑ [glutamine]blood + ↓ blood urea nitrogen (BUN)
- onset shortly after birth (< 1-3 day)
- hyperammonemia intoxication presents with
- cerebral edema, vomiting, hyperventilation, lethargy, blurring vision
- α-ketoglutarate consumed
- stops TCA cycle
- carbamoyl phosphate synthase I creates carbamoyl phosphate
- AR inheritance pattern
- orotic aciduria absent
- common presentation
- function
- Ammonia transport
- function
- safely move nitrogenous wastes from tissues to kidney and intestine in the form of glutamine
- function
- Glucose-alanine cycle
- function
- transport pyruvate from muscle to liver for gluconeogenesis
- pathway
- involves reversible aminotransferase reactions
- alanine aminotransferase (ALT)
- glutamate + pyruvate → α-ketoglutarate + alanine
- in muscle
- α-ketoglutarate + alanine → glutamate + pyruvate
- in liver
- requires vitamin B6
- glutamate + pyruvate → α-ketoglutarate + alanine
- aspartate aminotransferase (AST)
- glutamate + oxaloacetate → α-ketoglutarate + aspartate
- in liver
- glutamate + oxaloacetate → α-ketoglutarate + aspartate
- alanine aminotransferase (ALT)
- involves reversible aminotransferase reactions
- relationship between amino acids and α-keto acids
- alanine – NH3 = pyruvate
- aspartate – NH3 = oxaloacetate
- glutamate – NH3 = α-ketoglutarate
- function
- Defects in specific amino acid catabolism
- all are part of newborn screening program
- phenylketonuria (PKU)
- inability to break down phenylalanine
- deficient in phenylalanine hydroxylase
- ↓ tetrahydrobiopterin cofactor
- presentation
- mental retardation
- microcephaly
- musty/mousy odor to sweat and urine
- restriction of phenylalanine in the diet
- though cannot eliminate as it essential for protein synthesis
- very strict adherence to diet during pregnancy for a mother with PKU
- avoid aspartame
- inability to break down phenylalanine
- maple syrup urine disease
- inability to breakdown branched-chain amino acids (Val, Leu, Ile)
- deficient in branched-chain ketoacid dehydrogenase
- presentation
- infantile onset
- normal for first week
- progressive onset of symptoms
- lethargy
- weight loss
- hyper/hypotonia
- mental retardation
- urine smells of maple syrup
- death if dietary intake of Val, Leu, Ile is not restricted
- infantile onset
- inability to breakdown branched-chain amino acids (Val, Leu, Ile)
- alkaptonuria
- inability to breakdown homogentisic acid (breakdown product of tyrosine and phenylalanine)
- presentation
- arthritis
- accumulates over years in the cartilage (ochronosis)
- onset prior to third decade
- urine that darkens upon sitting in air
- dark coloration of the sclera
- arthritis
- Hartnup’s disease
- deficiency of neutral amino acid transporter
- leads to ↓ tryptophan absorption
- presentation
- pellagra
- result of niacin deficiency (niacin produced from tryptophan)
- deficiency of neutral amino acid transporter
- homocystinuria
- inability to breakdown homocystinuria (methionine degradation pathway)
- presentation
- vessel damage
- DVT
- atherosclerosis
- MI before 2nd decade of life
- similar to Marfan’s
- mental retardation
- lens dislocations
- downward
- as opposed to upward in Marfan syndrome
- tall with long extremities
- ↑ homocysteine in the urine
- vessel damage
- propionyl-CoA carboxylase/methylmalonyl-CoA deficiency
- inability to handle Val, Met, Ile, Thr
- part of propionic acid pathway
- presentation
- ketoacidosis
- propionyl-CoA carboxylase deficiency has ↑ propionic acid, methyl citrate, hydroxypropionic acid
- methylmalonyl-CoA mutase deficiency has ↑ methylmalonic acid
- treat by restricting Val, Met, Ile, Thr in the diet